Following a tumultuous year of lockdowns and loss, Canadians are wondering, what comes next? Canada’s experience of past disease outbreaks may provide clues to the post-pandemic future.
Liberals goal to boost bio-manufacturing in Canada inhibited by their own policies, industry says You can t do both. You can t take 70, 80, 90 per cent off the bottom line of businesses and expect them to be really happy about investing in the country
Author of the article: Ryan Tumilty
Publishing date: Apr 30, 2021 • 9 hours ago • 4 minute read • Federal Health Minister Patty Hajdu and Industry Minister François-Philippe Champagne announce $925-million in funding to expand Canada s vaccine manufacturing capacity with Sanofi Pasteur Ltd., March 31, 2021. Champagne says he is confident Canada can be reestablished as a leader in bio-manufacturing. Photo by Nathan Denette/The Canadian Press/File
Lack of Domestic Vaccines Has Raised Calls for Pharmaceutical Policy Reforms, While Some Advise Caution theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.
Innovation Minister François-Philippe Champagne says everyone wins with Canada s new plan to ramp up vaccine manufacturing capacity at home.
The federal government will spend $415 million on the partnership with the private company Sanofi Pasteur Ltd, Ontario s government will contribute $55 million to the project, and Sanofi will pitch in $455 million, as well as an extra $79 million a year to fund Canadian research and development.
The facility will primarily manufacture influenza vaccines, but have the ability to pivot to vaccines for coronaviruses and other diseases in the case of another pandemic. It won t be up and running until 2027.
Champagne spoke to
TORONTO On the heels of his Wednesday announcement regarding the federal government’s support for a new influenza vaccine manufacturing facility in Toronto, Industry Minister Francois-Philippe Champagne says he has plans to further improve the country’s domestic biomanufacturing capacity.
The federal government will spend $415 million, in partnership with Sanofi Pasteur Ltd. and the Ontario government, to build the vaccine facility by 2027. According to Champagne, the Toronto facility will be able to produce 76 million vaccine doses for influenza within six months of the World Health Organization declaring a pandemic, which will be enough to vaccinate the Canadian population and export any extra doses to other countries.